Reuters logo
BRIEF-Paion initiats second pivotal U.S. Phase III clinical trial of Remimazolam
June 8, 2015 / 12:11 PM / 2 years ago

BRIEF-Paion initiats second pivotal U.S. Phase III clinical trial of Remimazolam

June 8 (Reuters) - Paion AG :

* Announces initiation of second U.S. Phase III clinical trial of Remimazolam for procedural sedation during bronchoscopy Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below